[{"Assets_0_Q2_USD":5898496000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":185089000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":185427000.0,"StockholdersEquity_0_Q2_USD":4241571000.0,"RevenuesConverted_2_Q2_USD":987723000.0,"RevenuesConverted_1_Q2_USD":501693000.0,"NetIncomeLossConverted_2_Q2_USD":30312000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":182844000.0,"NetIncomeLossConverted_1_Q2_USD":12941000.0,"EarningsPerShareDiluted_2_Q2_USD":0.16,"EarningsPerShareDiluted_1_Q2_USD":0.07,"EarningsPerShareBasic_2_Q2_USD":0.17,"EarningsPerShareBasic_1_Q2_USD":0.07,"CommonStockSharesOutstanding_0_Q2_shares":183321820.0,"CommonStockSharesConverted_0_Q2_shares":183321820.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":196296000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":182311000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210730"}]